Newron Pharmaceuticals SpA Capital Reinvestment Ratio
Newron Pharmaceuticals SpA capital reinvestment ratio. Newron Pharmaceuticals SpA (NWRN) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (CHF33.35 Million) in capital expenditures (CHF31.00K). Check NWRN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Newron Pharmaceuticals SpA (2012–2025)
Capital reinvestment ratio of Newron Pharmaceuticals SpA from 2012 to 2025. This chart tracks Newron Pharmaceuticals SpA's Capital Reinvestment Ratio across 2 annual periods. Also explore Newron Pharmaceuticals SpA equity growth rate to track the company's year-over-year net asset growth rate.
Newron Pharmaceuticals SpA Capital Reinvestment Ratio by Year (2012–2025)
Newron Pharmaceuticals SpA capital reinvestment ratio by year from 2012 to 2025. For the full cash flow conversion analysis, see Newron Pharmaceuticals SpA (NWRN) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | CHF32.56 Million | CHF47.30K | ▼ -23.1% |
| 2012 | 0.00x | CHF5.83 Million | CHF11.00K | — |